Artificial Kidney Comprehensive Study by Type (Wearable Artificial Kidney, Implantable Artificial Kidney), Application (Adults, Pediatrics) Players and Region - Global Market Outlook to 2026

Artificial Kidney Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Growing geriatric population, increasing disposable income and rising life expectancy are expected to boost the market of Artificial Kidney Market. Kidney disease is the 9th leading cause of death in the country. According to the National Kidney Foundation around 10% of the population is suffering from chronic kidney diseases globally. Artificial Kidney refers to a device used to filter the blood of the person suffering from kidney damage. It is also known as haemodialyzer. The artificial kidney replicates the work of real kidney and eliminated the need of for dialysis. It helps to produce the hormone, regulate blood pressure, promote red cell and support bone health. It reduces the kidney disease and allows the patient to stay quality life.This growth is primarily driven by Rising Pool of Patients Suffering From Kidney Damage Owing to Aging & Age Related Disorder, Rising In the Disposable Income and Rise in Number of People Awaiting Organ Transplant.

Globally, a noticeable market trend is evident Technology Advancement in Field Of Science. Major Players, such as Baxter International Inc. (United States), Xcorporeal Inc. (United States), Medtronic, (United States), DaVita Inc. (United States), Merit Medical Systems, Inc. (United States), NIPRO Medical Corporation (United States), NxStage (United States), SynCardia Systems (United States), B. Braun Melsungen AG (Germany) and Fresenius (Germany) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:

According to the National Kidney Foundation, " Around 10% of the population are suffering from chronic kidney diseases globally. About two million patients are either under the treatment of dialysis or need a kidney transplant to stay alive." In the global geriatric population, age between 65 to 74, it is predicted that one in five men and one in four women are suffering from chronic kidney diseases. About more than 30 Million American diseases.

Regulatory Insights:
FDA approves the clinical testing of a wearable artificial kidney developed by the University of Washington Medical Center. Going forward, wearable artificial kidney systems are expected to be portable, lightweight, user-friendly, smaller, and more convenient.

Market Drivers
  • Rising Pool of Patients Suffering From Kidney Damage Owing to Aging & Age Related Disorder
  • Rising In the Disposable Income
  • Rise in Number of People Awaiting Organ Transplant

Market Trend
  • Technology Advancement in Field Of Science

Restraints
  • High Cost of Artificial Kidney Hamper Broader Adoption

Opportunities
Growing Awareness about Artificial Kidney
Challenges
Lack of Surgical Expertise

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Artificial Kidney Study Sheds Light on
— The Artificial Kidney Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Artificial Kidney industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Artificial Kidney industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Wearable Artificial Kidney
  • Implantable Artificial Kidney
By Application
  • Adults
  • Pediatrics
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Pool of Patients Suffering From Kidney Damage Owing to Aging & Age Related Disorder
      • 3.2.2. Rising In the Disposable Income
      • 3.2.3. Rise in Number of People Awaiting Organ Transplant
    • 3.3. Market Challenges
      • 3.3.1. Lack of Surgical Expertise
    • 3.4. Market Trends
      • 3.4.1. Technology Advancement in Field Of Science
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Artificial Kidney, by Type, Application and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Artificial Kidney (Value)
      • 5.2.1. Global Artificial Kidney by: Type (Value)
        • 5.2.1.1. Wearable Artificial Kidney
        • 5.2.1.2. Implantable Artificial Kidney
      • 5.2.2. Global Artificial Kidney by: Application (Value)
        • 5.2.2.1. Adults
        • 5.2.2.2. Pediatrics
      • 5.2.3. Global Artificial Kidney Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Artificial Kidney (Price)
      • 5.3.1. Global Artificial Kidney by: Type (Price)
  • 6. Artificial Kidney: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Baxter International Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Xcorporeal Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Medtronic, (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. DaVita Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Merit Medical Systems, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. NIPRO Medical Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. NxStage (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. SynCardia Systems (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. B. Braun Melsungen AG (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Fresenius (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Artificial Kidney Sale, by Type, Application and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Artificial Kidney (Value)
      • 7.2.1. Global Artificial Kidney by: Type (Value)
        • 7.2.1.1. Wearable Artificial Kidney
        • 7.2.1.2. Implantable Artificial Kidney
      • 7.2.2. Global Artificial Kidney by: Application (Value)
        • 7.2.2.1. Adults
        • 7.2.2.2. Pediatrics
      • 7.2.3. Global Artificial Kidney Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Artificial Kidney (Price)
      • 7.3.1. Global Artificial Kidney by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Artificial Kidney: by Type(USD Million)
  • Table 2. Artificial Kidney Wearable Artificial Kidney , by Region USD Million (2015-2020)
  • Table 3. Artificial Kidney Implantable Artificial Kidney , by Region USD Million (2015-2020)
  • Table 4. Artificial Kidney: by Application(USD Million)
  • Table 5. Artificial Kidney Adults , by Region USD Million (2015-2020)
  • Table 6. Artificial Kidney Pediatrics , by Region USD Million (2015-2020)
  • Table 7. South America Artificial Kidney, by Country USD Million (2015-2020)
  • Table 8. South America Artificial Kidney, by Type USD Million (2015-2020)
  • Table 9. South America Artificial Kidney, by Application USD Million (2015-2020)
  • Table 10. Brazil Artificial Kidney, by Type USD Million (2015-2020)
  • Table 11. Brazil Artificial Kidney, by Application USD Million (2015-2020)
  • Table 12. Argentina Artificial Kidney, by Type USD Million (2015-2020)
  • Table 13. Argentina Artificial Kidney, by Application USD Million (2015-2020)
  • Table 14. Rest of South America Artificial Kidney, by Type USD Million (2015-2020)
  • Table 15. Rest of South America Artificial Kidney, by Application USD Million (2015-2020)
  • Table 16. Asia Pacific Artificial Kidney, by Country USD Million (2015-2020)
  • Table 17. Asia Pacific Artificial Kidney, by Type USD Million (2015-2020)
  • Table 18. Asia Pacific Artificial Kidney, by Application USD Million (2015-2020)
  • Table 19. China Artificial Kidney, by Type USD Million (2015-2020)
  • Table 20. China Artificial Kidney, by Application USD Million (2015-2020)
  • Table 21. Japan Artificial Kidney, by Type USD Million (2015-2020)
  • Table 22. Japan Artificial Kidney, by Application USD Million (2015-2020)
  • Table 23. India Artificial Kidney, by Type USD Million (2015-2020)
  • Table 24. India Artificial Kidney, by Application USD Million (2015-2020)
  • Table 25. South Korea Artificial Kidney, by Type USD Million (2015-2020)
  • Table 26. South Korea Artificial Kidney, by Application USD Million (2015-2020)
  • Table 27. Taiwan Artificial Kidney, by Type USD Million (2015-2020)
  • Table 28. Taiwan Artificial Kidney, by Application USD Million (2015-2020)
  • Table 29. Australia Artificial Kidney, by Type USD Million (2015-2020)
  • Table 30. Australia Artificial Kidney, by Application USD Million (2015-2020)
  • Table 31. Rest of Asia-Pacific Artificial Kidney, by Type USD Million (2015-2020)
  • Table 32. Rest of Asia-Pacific Artificial Kidney, by Application USD Million (2015-2020)
  • Table 33. Europe Artificial Kidney, by Country USD Million (2015-2020)
  • Table 34. Europe Artificial Kidney, by Type USD Million (2015-2020)
  • Table 35. Europe Artificial Kidney, by Application USD Million (2015-2020)
  • Table 36. Germany Artificial Kidney, by Type USD Million (2015-2020)
  • Table 37. Germany Artificial Kidney, by Application USD Million (2015-2020)
  • Table 38. France Artificial Kidney, by Type USD Million (2015-2020)
  • Table 39. France Artificial Kidney, by Application USD Million (2015-2020)
  • Table 40. Italy Artificial Kidney, by Type USD Million (2015-2020)
  • Table 41. Italy Artificial Kidney, by Application USD Million (2015-2020)
  • Table 42. United Kingdom Artificial Kidney, by Type USD Million (2015-2020)
  • Table 43. United Kingdom Artificial Kidney, by Application USD Million (2015-2020)
  • Table 44. Netherlands Artificial Kidney, by Type USD Million (2015-2020)
  • Table 45. Netherlands Artificial Kidney, by Application USD Million (2015-2020)
  • Table 46. Rest of Europe Artificial Kidney, by Type USD Million (2015-2020)
  • Table 47. Rest of Europe Artificial Kidney, by Application USD Million (2015-2020)
  • Table 48. MEA Artificial Kidney, by Country USD Million (2015-2020)
  • Table 49. MEA Artificial Kidney, by Type USD Million (2015-2020)
  • Table 50. MEA Artificial Kidney, by Application USD Million (2015-2020)
  • Table 51. Middle East Artificial Kidney, by Type USD Million (2015-2020)
  • Table 52. Middle East Artificial Kidney, by Application USD Million (2015-2020)
  • Table 53. Africa Artificial Kidney, by Type USD Million (2015-2020)
  • Table 54. Africa Artificial Kidney, by Application USD Million (2015-2020)
  • Table 55. North America Artificial Kidney, by Country USD Million (2015-2020)
  • Table 56. North America Artificial Kidney, by Type USD Million (2015-2020)
  • Table 57. North America Artificial Kidney, by Application USD Million (2015-2020)
  • Table 58. United States Artificial Kidney, by Type USD Million (2015-2020)
  • Table 59. United States Artificial Kidney, by Application USD Million (2015-2020)
  • Table 60. Canada Artificial Kidney, by Type USD Million (2015-2020)
  • Table 61. Canada Artificial Kidney, by Application USD Million (2015-2020)
  • Table 62. Mexico Artificial Kidney, by Type USD Million (2015-2020)
  • Table 63. Mexico Artificial Kidney, by Application USD Million (2015-2020)
  • Table 64. Artificial Kidney: by Type(USD/Units)
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Artificial Kidney: by Type(USD Million)
  • Table 76. Artificial Kidney Wearable Artificial Kidney , by Region USD Million (2021-2026)
  • Table 77. Artificial Kidney Implantable Artificial Kidney , by Region USD Million (2021-2026)
  • Table 78. Artificial Kidney: by Application(USD Million)
  • Table 79. Artificial Kidney Adults , by Region USD Million (2021-2026)
  • Table 80. Artificial Kidney Pediatrics , by Region USD Million (2021-2026)
  • Table 81. South America Artificial Kidney, by Country USD Million (2021-2026)
  • Table 82. South America Artificial Kidney, by Type USD Million (2021-2026)
  • Table 83. South America Artificial Kidney, by Application USD Million (2021-2026)
  • Table 84. Brazil Artificial Kidney, by Type USD Million (2021-2026)
  • Table 85. Brazil Artificial Kidney, by Application USD Million (2021-2026)
  • Table 86. Argentina Artificial Kidney, by Type USD Million (2021-2026)
  • Table 87. Argentina Artificial Kidney, by Application USD Million (2021-2026)
  • Table 88. Rest of South America Artificial Kidney, by Type USD Million (2021-2026)
  • Table 89. Rest of South America Artificial Kidney, by Application USD Million (2021-2026)
  • Table 90. Asia Pacific Artificial Kidney, by Country USD Million (2021-2026)
  • Table 91. Asia Pacific Artificial Kidney, by Type USD Million (2021-2026)
  • Table 92. Asia Pacific Artificial Kidney, by Application USD Million (2021-2026)
  • Table 93. China Artificial Kidney, by Type USD Million (2021-2026)
  • Table 94. China Artificial Kidney, by Application USD Million (2021-2026)
  • Table 95. Japan Artificial Kidney, by Type USD Million (2021-2026)
  • Table 96. Japan Artificial Kidney, by Application USD Million (2021-2026)
  • Table 97. India Artificial Kidney, by Type USD Million (2021-2026)
  • Table 98. India Artificial Kidney, by Application USD Million (2021-2026)
  • Table 99. South Korea Artificial Kidney, by Type USD Million (2021-2026)
  • Table 100. South Korea Artificial Kidney, by Application USD Million (2021-2026)
  • Table 101. Taiwan Artificial Kidney, by Type USD Million (2021-2026)
  • Table 102. Taiwan Artificial Kidney, by Application USD Million (2021-2026)
  • Table 103. Australia Artificial Kidney, by Type USD Million (2021-2026)
  • Table 104. Australia Artificial Kidney, by Application USD Million (2021-2026)
  • Table 105. Rest of Asia-Pacific Artificial Kidney, by Type USD Million (2021-2026)
  • Table 106. Rest of Asia-Pacific Artificial Kidney, by Application USD Million (2021-2026)
  • Table 107. Europe Artificial Kidney, by Country USD Million (2021-2026)
  • Table 108. Europe Artificial Kidney, by Type USD Million (2021-2026)
  • Table 109. Europe Artificial Kidney, by Application USD Million (2021-2026)
  • Table 110. Germany Artificial Kidney, by Type USD Million (2021-2026)
  • Table 111. Germany Artificial Kidney, by Application USD Million (2021-2026)
  • Table 112. France Artificial Kidney, by Type USD Million (2021-2026)
  • Table 113. France Artificial Kidney, by Application USD Million (2021-2026)
  • Table 114. Italy Artificial Kidney, by Type USD Million (2021-2026)
  • Table 115. Italy Artificial Kidney, by Application USD Million (2021-2026)
  • Table 116. United Kingdom Artificial Kidney, by Type USD Million (2021-2026)
  • Table 117. United Kingdom Artificial Kidney, by Application USD Million (2021-2026)
  • Table 118. Netherlands Artificial Kidney, by Type USD Million (2021-2026)
  • Table 119. Netherlands Artificial Kidney, by Application USD Million (2021-2026)
  • Table 120. Rest of Europe Artificial Kidney, by Type USD Million (2021-2026)
  • Table 121. Rest of Europe Artificial Kidney, by Application USD Million (2021-2026)
  • Table 122. MEA Artificial Kidney, by Country USD Million (2021-2026)
  • Table 123. MEA Artificial Kidney, by Type USD Million (2021-2026)
  • Table 124. MEA Artificial Kidney, by Application USD Million (2021-2026)
  • Table 125. Middle East Artificial Kidney, by Type USD Million (2021-2026)
  • Table 126. Middle East Artificial Kidney, by Application USD Million (2021-2026)
  • Table 127. Africa Artificial Kidney, by Type USD Million (2021-2026)
  • Table 128. Africa Artificial Kidney, by Application USD Million (2021-2026)
  • Table 129. North America Artificial Kidney, by Country USD Million (2021-2026)
  • Table 130. North America Artificial Kidney, by Type USD Million (2021-2026)
  • Table 131. North America Artificial Kidney, by Application USD Million (2021-2026)
  • Table 132. United States Artificial Kidney, by Type USD Million (2021-2026)
  • Table 133. United States Artificial Kidney, by Application USD Million (2021-2026)
  • Table 134. Canada Artificial Kidney, by Type USD Million (2021-2026)
  • Table 135. Canada Artificial Kidney, by Application USD Million (2021-2026)
  • Table 136. Mexico Artificial Kidney, by Type USD Million (2021-2026)
  • Table 137. Mexico Artificial Kidney, by Application USD Million (2021-2026)
  • Table 138. Artificial Kidney: by Type(USD/Units)
  • Table 139. Research Programs/Design for This Report
  • Table 140. Key Data Information from Secondary Sources
  • Table 141. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Artificial Kidney: by Type USD Million (2015-2020)
  • Figure 5. Global Artificial Kidney: by Application USD Million (2015-2020)
  • Figure 6. South America Artificial Kidney Share (%), by Country
  • Figure 7. Asia Pacific Artificial Kidney Share (%), by Country
  • Figure 8. Europe Artificial Kidney Share (%), by Country
  • Figure 9. MEA Artificial Kidney Share (%), by Country
  • Figure 10. North America Artificial Kidney Share (%), by Country
  • Figure 11. Global Artificial Kidney: by Type USD/Units (2015-2020)
  • Figure 12. Global Artificial Kidney share by Players 2020 (%)
  • Figure 13. Global Artificial Kidney share by Players (Top 3) 2020(%)
  • Figure 14. Global Artificial Kidney share by Players (Top 5) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Baxter International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Baxter International Inc. (United States) Revenue: by Geography 2020
  • Figure 18. Xcorporeal Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Xcorporeal Inc. (United States) Revenue: by Geography 2020
  • Figure 20. Medtronic, (United States) Revenue, Net Income and Gross profit
  • Figure 21. Medtronic, (United States) Revenue: by Geography 2020
  • Figure 22. DaVita Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. DaVita Inc. (United States) Revenue: by Geography 2020
  • Figure 24. Merit Medical Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Merit Medical Systems, Inc. (United States) Revenue: by Geography 2020
  • Figure 26. NIPRO Medical Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 27. NIPRO Medical Corporation (United States) Revenue: by Geography 2020
  • Figure 28. NxStage (United States) Revenue, Net Income and Gross profit
  • Figure 29. NxStage (United States) Revenue: by Geography 2020
  • Figure 30. SynCardia Systems (United States) Revenue, Net Income and Gross profit
  • Figure 31. SynCardia Systems (United States) Revenue: by Geography 2020
  • Figure 32. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 33. B. Braun Melsungen AG (Germany) Revenue: by Geography 2020
  • Figure 34. Fresenius (Germany) Revenue, Net Income and Gross profit
  • Figure 35. Fresenius (Germany) Revenue: by Geography 2020
  • Figure 36. Global Artificial Kidney: by Type USD Million (2021-2026)
  • Figure 37. Global Artificial Kidney: by Application USD Million (2021-2026)
  • Figure 38. South America Artificial Kidney Share (%), by Country
  • Figure 39. Asia Pacific Artificial Kidney Share (%), by Country
  • Figure 40. Europe Artificial Kidney Share (%), by Country
  • Figure 41. MEA Artificial Kidney Share (%), by Country
  • Figure 42. North America Artificial Kidney Share (%), by Country
  • Figure 43. Global Artificial Kidney: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Baxter International Inc. (United States)
  • Xcorporeal Inc. (United States)
  • Medtronic, (United States)
  • DaVita Inc. (United States)
  • Merit Medical Systems, Inc. (United States)
  • NIPRO Medical Corporation (United States)
  • NxStage (United States)
  • SynCardia Systems (United States)
  • B. Braun Melsungen AG (Germany)
  • Fresenius (Germany)
Additional players considered in the study are as follows:
Kawasumi Laboratories, Inc. (Japan) , Nikkiso Co. Ltd. (Japan) , Asahi Kasei Medical Vo., Ltd. (Japan)
Select User Access Type

Key Highlights of Report


Sep 2021 212 Pages 84 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2016-2020; Base year: 2020; Forecast period: 2021 to 2026
Companies that are profiled in Global Artificial Kidney Market are Baxter International Inc. (United States), Xcorporeal Inc. (United States), Medtronic, (United States), DaVita Inc. (United States), Merit Medical Systems, Inc. (United States), NIPRO Medical Corporation (United States), NxStage (United States), SynCardia Systems (United States), B. Braun Melsungen AG (Germany) and Fresenius (Germany) etc.
Growing geriatric population, increasing disposable income and rising life expectancy are expected to boost the market of Artificial Kidney Market. Kidney disease is the 9th leading cause of death in the country. According to the National Kidney Foundation around 10% of the population is suffering from chronic kidney diseases globally. Artificial Kidney refers to a device used to filter the blood of the person suffering from kidney damage. It is also known as haemodialyzer. The artificial kidney replicates the work of real kidney and eliminated the need of for dialysis. It helps to produce the hormone, regulate blood pressure, promote red cell and support bone health. It reduces the kidney disease and allows the patient to stay quality life.

Know More About Global Artificial Kidney Market Report?